Adverum Biotechnologies

About:

Adverum Biotechnologies is a gene therapy company that focuses on developing medicines that can offer therapeutic benefits to patients.

Website: http://adverum.com/

Twitter/X: avalanchebio

Top Investors: Deerfield, Samsara BioCapital, Frazier Life Sciences, Vivo Capital, 5AM Ventures

Description:

Adverum Biotechnologies is a clinical-stage company that aims to establish gene therapy as a new standard of care for a number of highly prevalent ocular diseases with the aspiration of developing functional cures for these diseases to restore vision and prevent blindness. Their services include gene therapy, biotechnology, rare diseases, ophthalmology, and retina.

Total Funding Amount:

$815M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)adverum.com

Founders:

Mark S. Blumenkranz, Steven D. Schwartz, Thomas W. Chalberg, PhD

Number of Employees:

101-250

Last Funding Date:

2024-02-05

IPO Status:

Public

© 2025 bioDAO.ai